Comparing the activity of novel antibiotic agents against carbapenem-resistant Enterobacterales clinical isolates.
Pranita D TammaYehudit BergmanEmily B JacobsJae Hyoung LeeShawna LewisSara E CosgrovePatricia J Simnernull nullPublished in: Infection control and hospital epidemiology (2022)
Selection among novel agents requires a nuanced understanding of the molecular epidemiology of CRE. This work provides insights into the comparative activity of novel agents and the additive value of a second antibiotic for empiric antibiotic decision making.
Keyphrases